Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
On Wednesday, February 18, 2026, Ipsen's stock reached a new all-time high, hitting €156.80 during the session and surpassing the previous record set …
Deutsche Bank ajuste sa position sur Ipsen ce mardi 17 février 2026.
UBS ajuste ce vendredi sa position sur le laboratoire pharmaceutique français.
Ipsen's stock has seen significant progress this Friday, surpassing the 151 euro mark in the morning, following the release of its annual 2025 results…
The biopharmaceutical group Ipsen has published its 2025 financial results, showing an increase in revenue and operating income. For the current fisca…
Ipsen announces the co-option of Peter Guenter as a board member effective from January 28, 2026, filling the vacancy created by the departure of Henr…
Ipsen's stock fell 1.22% on Wednesday, closing at 137.70 euros after reaching 139.40 euros the day before. Nevertheless, the pharmaceutical company's …
Ipsen announces the appointment of Pierrick Lefranc as Executive Vice President and member of the Executive Committee effective April 1, 2026.
BNP Paribas Exane ajuste sa position sur le titre Ipsen ce lundi 26 janvier 2026.
The French biopharmaceutical group Ipsen has prevailed in the International Chamber of Commerce (ICC) Arbitration Tribunal, which dismissed Galderma's…
